Systems and methods for renal replacement therapy
The system addresses membrane fouling in HF and HDF treatments by temporarily adjusting fluid flow rates and implementing a flush and backwash, enhancing treatment efficiency and reducing heparin use, particularly beneficial for patients sensitive to anticoagulants.
Patent Information
- Application Number
- CN201880044173.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2017-06-28
- Filing Date
- 2018-06-21
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2038-06-21
AI Technical Summary
Membrane fouling in blood treatment units during high volume post-dilution hemofiltration (HF) and hemodiafiltration (HDF) treatments reduces water permeability and treatment efficiency, necessitating time-consuming cleaning procedures and the use of anticoagulants like heparin, which some patients cannot tolerate.
A system and method that includes a blood treatment unit with a semipermeable membrane, a blood pump, pre- and post-dilution lines for fluid infusion, and a control unit to manage membrane fouling by temporarily increasing the pre-dilution flow rate and reducing the post-dilution flow rate, accompanied by a flush and backwash to maintain treatment efficiency without heparin.
The system effectively reduces membrane fouling, maintains high ultrafiltration rates, and ensures efficient treatment by minimizing the use of heparin, suitable for patients who cannot tolerate anticoagulants.
Smart Images

Figure CN110809803B_ABST
Abstract
Description
Technical Field
[0001] The present disclosure relates to the field of renal replacement therapy for extracorporeal blood treatment, and more particularly to a system for renal replacement therapy, and a method for managing membrane fouling of a blood treatment unit in a system for renal replacement therapy. Background Art
[0002] Renal replacement therapy systems are used for patients who, for some reason, must have their blood treated outside of their body. Extracorporeal blood treatment can be used to extract undesirable substances or molecules from the patient's blood and, if necessary, to add desired substances or molecules to the blood. Extracorporeal blood treatment is accomplished by passing the blood through a blood treatment unit such as a dialyzer or a hemofilter. A membrane divides the treatment unit into a blood compartment and a fluid compartment. The blood drawn from the patient is introduced into the blood compartment and flows through the membrane. The membrane is semipermeable to selectively allow substances in the blood to flow from the blood compartment through the membrane into the fluid compartment. Depending on the type of treatment, the membrane also selectively allows substances in the fluid compartment to flow through the membrane into the blood compartment.
[0003] Many different types of extracorporeal blood treatment can be performed. In an ultrafiltration (UF) treatment, undesirable substances are removed from the blood by convection across a membrane into a fluid compartment. In a hemofiltration (HF) treatment, as in a UF treatment, the blood flows through a membrane, and desired substances are typically added to the blood by dispensing fluid into the blood before and / or after it passes through a treatment unit and before it is returned to the patient. In a hemodialysis (HD) treatment, a secondary fluid containing undesirable substances is introduced into a fluid compartment of a treatment unit. Undesirable substances from the blood cross the membrane into the secondary fluid, and desired substances from the secondary fluid can cross the membrane into the blood. In a hemodiafiltration (HDF) treatment, as in HD, the blood and the secondary fluid exchange substances, and additionally, as in HF, substances are typically added to the blood by dispensing fluid into the treated blood before it is returned to the patient.
[0004] Traditionally, the coagulation (coagulation) of blood, also known as coagulation (clotting), is reduced by using anticoagulants such as heparin. However, during treatment, substances from the blood (such as coagulated blood, proteins, etc.) may begin to clog the membrane of the treatment unit. This phenomenon can be called membrane scaling. The impact on the membrane is a gradual decrease in flow and a change in membrane selectivity. Membrane scaling is mainly caused by concentration polarization and adsorption or deposition of proteins on the surface or in its pores. Concentration polarization is the result of the concentration gradient caused by the accumulation of solutes near the membrane surface. This solute accumulation is also called a secondary membrane. The adsorption or deposition of proteins on the surface or in its pores is caused by the adsorption or capture of proteins in the pores of the membrane, thereby changing the membrane properties. When the area of the membrane begins to become less effective, measures must be taken to maintain the same treatment efficiency.
[0005] Previously, membrane fouling was managed by cleaning the blood circuit and replacing filters. However, these procedures were time-consuming and necessitated stopping the process.
[0006] It is known from WO2014 / 095073A1 that the transmembrane pressure (TMP), hematocrit (HCT) or blood density are controlled by adjusting at least one of the infusion rates of the replacement fluid added upstream and / or downstream of the treatment unit. Thus, the stacking limiting secondary membrane on the membrane in the blood treatment unit can be kept constant, thereby achieving a constant blood purification effect. For example, in the case of high TMP or high HKT values of blood, the infusion rate of the replacement fluid added upstream can be increased until the desired value of the control value is reached. However, diluting the blood upstream of the treatment unit changes the blood composition, and its effect on the treatment efficiency is still controversial. Summary of the invention
[0007] In HF and HDF treatments, especially high volume HF and HDF treatments, it is desirable in most cases to add as much replacement fluid as possible downstream of the treatment unit, since the blood thereby becomes more concentrated in the treatment unit with a positive effect on the treatment efficiency.
[0008] However, membrane fouling limits water permeability through the membrane, and the reduced permeability reduces the convective volume achievable during processing.
[0009] Therefore, there is a need for an improved method to manage fouling in blood processing units, especially in high volume post-dilution HF processing and HDF processing.
[0010] It is an object of the present disclosure to alleviate at least some of the disadvantages of the prior art. Another object is to provide a system and method for managing membrane fouling of a blood treatment unit. Yet another object is to provide a system and method for managing membrane fouling of a blood treatment unit in high volume post-dilution HF treatment and HDF treatment. Another object is to provide a system and method for managing membrane fouling so as to improve treatment efficiency. Another object is to reduce the use of heparin or other anticoagulants during treatment. Some patients cannot tolerate anticoagulant drugs, and for these patients a so-called heparin-free treatment is used. In such a treatment, the membrane will be particularly susceptible to fouling.
[0011] These and other objects are at least partly achieved by systems and methods according to the independent claims and by embodiments according to the dependent claims.
[0012] According to a first aspect, the present disclosure relates to a system for renal replacement therapy, the system comprising a blood treatment unit, the blood treatment unit being arranged to be connected to a blood circuit for extracorporeal blood circulation, the blood circuit comprising an arterial line and a venous line. The blood treatment unit comprises a blood compartment and a fluid compartment separated by a semipermeable membrane. The system further comprises: a blood pump, arranged to generate a blood flow rate Q in the arterial line B a pre-dilution line arranged for infusing a replacement fluid upstream of a processing unit; a post-dilution line arranged for infusing a replacement fluid downstream of a processing unit; a flow control device arranged to adjust a pre-dilution flow rate Q of the replacement fluid in the pre-dilution line pre and the post-dilution flow rate Q of the replacement fluid in the post-dilution line post The system further comprises a control unit configured to control the system according to control instructions. The control instructions comprise: during the treatment, determining a system parameter value and determining a membrane fouling indication of the membrane based on a predetermined criterion of the determined system parameter value, and activating an automatic anti-fouling measure, the automatic anti-fouling measure comprising: in order to generate a flush of the blood treatment unit, during at least one time period Δt1, respectively, from a pre-dilution flow rate Q pre and post-dilution flow rate Q post The current flow rate temporarily increases the predilution flow rate Q pre and temporarily reduce the dilution flow rate Q post , wherein the temporary increase includes increasing the pre-dilution flow rate Q pre Increased to a value exceeding the post-dilution flow rate Q before the anti-fouling measures are activated post has a value of 100%.
[0013] Utilize described system, membrane fouling is offset, and membrane fouling is reduced.Thus, can realize comprehensive and more efficient treatment.Due to increase pre-dilution flow rate during predetermined short time period Δt1, therefore can keep pre-dilution fluid addition amount small and support high-efficiency treatment thereby.The membrane becomes more permeable, thereby can reduce the influence on ultrafiltration speed in HF treatment and HDF treatment, that is, can keep higher ultrafiltration speed, thus overall higher post-dilution flow rate.Compared with having pre-dilution flow rate (wherein, the addition amount of pre-dilution fluid becomes very large, so that changes the property of treatment) in longer time period, described temporary increase pre-dilution flow rate and temporary reduction post-dilution flow rate during same time period Δt1 have the advantage of high-efficiency treatment, and the influence on treatment property is very little or very short.In addition, can use less heparin or do not use heparin, this is useful for most patients, especially for patients who cannot use heparin.
[0014] As a further illustration: When fluid is added upstream of the blood treatment unit, the blood becomes more dilute and easier to filter out. The ultrafiltration rate of the system can then be increased. However, because the blood is diluted, the "system clearance" (i.e., the clearance of undiluted blood) will be reduced by the pre-dilution factor. Systems according to the present disclosure are able to achieve average high ultrafiltration rates while providing average high system clearance.
[0015] According to some embodiments, the anti-fouling measure comprises temporarily stopping the post-dilution flow rate Q during the at least one time period Δt1 post .
[0016] According to some embodiments, the system further comprises a dialysis fluid circuit comprising a supply line arranged for supplying dialysis fluid to a blood treatment unit, and a discharge line arranged for withdrawing used fluid from the blood treatment unit, wherein the anti-fouling measure comprises performing a backwash comprising infusing a volume of dialysis fluid from the fluid compartment into the blood compartment through a semipermeable membrane.
[0017] According to some embodiments, the anti-fouling measure comprises synchronizing the timing of the backwash with the timing of the flushing, so that the backwash affects the blood treatment unit at the same time as the flushing affects the blood treatment unit and / or the backwash affects the blood treatment unit earlier than the flushing affects the blood treatment unit.
[0018] According to some embodiments, the predetermined criterion comprises a limit value of a system parameter value, the control instruction comprises comparing the determined system parameter value with the limit value of the system parameter, and controlling the anti-fouling measure based on the comparison result.
[0019] According to some embodiments, the control instruction comprises determining a length of the at least one time period Δt1 based on the comparison result.
[0020] According to some embodiments, the at least one time period Δt1 has a length of 0.1 seconds - 6 seconds.
[0021] According to some embodiments, the system parameter to be determined is based on the current I consumed by the motor of the blood pump B 、System pressure P bi , transmembrane pressure TMP across the blood treatment unit, blood concentration C E , post-dilution flow rate Q post , ultrafiltration UF coefficient, treatment removal K and / or one or more of other efficiency parameters of the treatment. System parameters can also be determined based on any combination of specific parameters.
[0022] According to some embodiments, the control instructions include controlling the ultrafiltration rate and / or the post-dilution flow rate after the anti-fouling measure such that any temporary change in the ultrafiltration rate and / or the temporary change in the post-dilution flow rate is compensated for during the remaining treatment. Thus, the anti-fouling measure will not have any effect on the amount of fluid withdrawn from the patient.
[0023] According to a second aspect, the present disclosure relates to a method for use in a renal replacement therapy system, the system comprising a blood treatment unit, the blood treatment unit being arranged to be connected to a blood circuit for extracorporeal blood circulation and an arterial line and a venous line. The blood treatment unit comprises a blood compartment and a fluid compartment separated by a semipermeable membrane. The system further comprises: a blood pump, arranged to generate a blood flow rate Q in the arterial line B ; a pre-dilution line arranged for infusing a substitution fluid upstream of a treatment unit; a post-dilution line arranged for infusing a substitution fluid downstream of the treatment unit; a flow control device arranged for adjusting a pre-dilution flow rate of the substitution fluid in the pre-dilution line and a post-dilution flow rate of the substitution fluid in the post-dilution line; and a control unit. The method comprises during treatment: determining a system parameter value; determining a membrane fouling indication of a membrane based on a predetermined criterion of the determined system parameter value; activating an automatic anti-fouling measure, the automatic anti-fouling measure comprising: in order to generate a flush of the blood treatment unit, during at least one time period Δt1, respectively, from the pre-dilution flow rate Q pre and post-dilution flow rate Q post The current flow rate temporarily increases the predilution flow rate Q pre and temporarily reduce the dilution flow rate Q post , wherein the temporary increase includes increasing the pre-dilution flow rate Q pre Increased to a value exceeding the post-dilution flow rate Q before the anti-fouling measures are activated post has a value of 100%.
[0024] The same advantages as those of the system can be achieved by means of the method.
[0025] According to some embodiments, the anti-fouling measure comprises temporarily stopping the post-dilution flow rate Q during the at least one time period Δt1 post .
[0026] According to some embodiments, the anti-fouling measure comprises performing a backwash comprising infusing a volume of dialysis fluid from the fluid compartment into the blood compartment through a semi-permeable membrane.
[0027] According to some embodiments, the method comprises synchronizing the timing of the backwash with the timing of the flushing such that the backwash affects the blood treatment unit simultaneously with the flushing affecting the blood treatment unit and / or affects the blood treatment unit earlier than the flushing affects the blood treatment unit.
[0028] According to some embodiments, the predetermined criteria include a limit value of a system parameter value, and the method comprises:
[0029] - comparing the determined system parameter value with a limit value of the system parameter; and
[0030] - Control antifouling measures based on the comparison results.
[0031] According to some embodiments, the method comprises determining a length of the at least one time period Δt1 based on the comparison result.
[0032] According to some embodiments, the method comprises controlling the time of the at least one time period Δt1 based on the comparison result.
[0033] According to some embodiments, determining the system parameter is based on the current I consumed by the motor of the blood pump B 、System pressure P bi , transmembrane pressure TMP across the blood treatment unit, blood concentration C E , post-dilution flow rate Q post , ultrafiltration UF coefficient, treatment removal K and / or one or more of other efficiency parameters of the treatment. System parameters can also be determined based on any combination of specific parameters.
[0034] According to some embodiments, the method comprises controlling the ultrafiltration rate and / or the post-dilution flow rate after the anti-fouling measure such that any temporary change in the ultrafiltration rate and / or temporary change in the post-dilution flow rate is compensated during the remaining treatment.
[0035] According to a third aspect, the present disclosure relates to a computer program at a system, wherein the computer program comprises computer instructions to cause a control unit to perform a method according to any of the steps as described herein.
[0036] According to a fourth aspect, the present disclosure relates to a computer program product comprising computer instructions stored on a computer readable medium, the computer instructions being for performing a method according to any of the steps as described herein. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1 A system for renal replacement therapy according to some embodiments is shown.
[0038] Figure 2 Diagram showing membrane flushing according to some embodiments.
[0039] Figure 3 A diagram showing membrane flushing according to another embodiment.
[0040] Figure 4 A method for a renal replacement treatment system according to some embodiments is shown. DETAILED DESCRIPTION
[0041] exist Figure 1 1 shows a renal replacement therapy system 1. The system 1 comprises an extracorporeal blood circuit 2, a dialysis fluid circuit 3 and a blood treatment unit 4. The blood treatment unit 4 may be a filter unit or a dialyzer. The blood treatment unit 4 comprises a blood compartment 5 and a fluid compartment 6 separated by a semipermeable membrane 7. The semipermeable membrane 7 may be made of a plurality of hollow fibers.
[0042] The extracorporeal blood circuit 2 comprises an arterial line 15 connected to an inlet of a blood compartment 5 of a blood treatment unit 4, and a venous line 16 connected to an outlet of the blood compartment 5 of the blood treatment unit 4. Thus, the blood treatment unit 4 is arranged to be connected to the blood circuit 2 for extracorporeal blood circulation. The arterial line 15 is equipped with a blood pump 19, which is arranged to generate a blood flow rate Q in the arterial line 15. B . The blood pump 19 may be a peristaltic blood pump. The venous line 16 is equipped with a drip chamber 13. The arterial line 15 may be equipped with an auxiliary drip chamber (not shown) downstream of the blood pump 19. The motor 37 is arranged to rotate the blood pump 19. The motor 37 may be a brushed or brushless DC motor. A motor controller regulates the rotation speed of the blood pump 19. The speed of the blood pump 19 expressed in revolutions per minute (RPM) regulates the blood flow rate Q in the arterial line 15 B The blood pump speed depends on the voltage applied to the motor 37. In addition, the blood flow rate Q in the arterial line downstream of the blood pump 19 is B Mainly proportional to the blood pump speed. This ratio is based on the volume stroke volume of the blood pump, which is almost constant. However, due to long-term use of the pump segment, the pump pressure P in , pump current I BThere is a small but sometimes important deviation in the ratio between voltage and flow, etc. However, there are different types of correction means to account for this deviation and they can be used if a better and more accurate prediction of the blood flow rate is required. Thus, the blood flow rate Q can be derived from the blood pump speed B .
[0043] The current I consumed by the motor 37 B Proportional to the pressure difference across the pump, if the arterial pressure P is measured (or known to the system) in , the system pressure P can be easily calculated bi , which will be explained further below. Therefore, the current I B Derivation of system pressure P bi The current I consumed by the motor 37 can be directly measured using the built-in sensor. B The voltage can be measured by means of another built-in sensor. The arterial pressure P is measured by means of a pressure sensor 38 arranged in the arterial line 15 upstream of the blood pump 19. in .
[0044] The dialysis fluid circuit 3 comprises a supply line 17 and a discharge line 18. The supply line 17 is connected to the inlet of the fluid compartment 6 of the blood treatment unit 4 and the discharge line 18 is connected to the outlet of the fluid compartment 6 of the blood treatment unit 4. The supply line 17 is equipped with a fresh dialysis fluid pump 20, which is arranged to generate a fresh dialysis fluid flow rate Q di The discharge line 18 is equipped with a discharge pump 29, which is arranged to generate a used fluid flow rate Q drain In use, the upstream end of the supply line 17 is connected to a source of fresh dialysis fluid (not shown). The downstream end of the drain line 18 is connected to a container (not shown) for accumulating spent dialysis fluid or to a tank (not shown).
[0045] In some embodiments, the auxiliary line 21 is connected to the discharge line 18 between the blood treatment unit 4 and the discharge pump 29 and is equipped with an ultrafiltration pump 22, which is arranged to supply the desired weight loss rate WLR. The ultrafiltration pump 22 is arranged to cause ultrafiltration of plasma water through the membrane 7 of the blood treatment unit 4. Instead of having two pumps 22, 29, the discharge line 18 and the auxiliary line 21, the flow rate Q of the discharge pump 29 drain It can be increased to also pump out the WL amount (and therefore the WL rate). In the operation of the discharge pump 29, the flow rate Q of the discharge pump 29 drain Then for Q di Add the desired WLR. Then the UF pump 22 and the auxiliary line 21 are not required.
[0046] The discharge line 18 may be equipped with a discharge flow restriction 36 for controlling the fluid flow in the discharge line 18. The discharge flow restriction 36 may be arranged downstream of the blood treatment unit 4, but upstream of any auxiliary line 21. The discharge flow restriction 36 may be a valve group. The valve group may be an electromechanically actuated valve group.
[0047] The infusion line set 8 is connected to the extracorporeal blood circuit 2. The infusion line set 8 comprises a main line 9 which branches into a pre-dilution line 10 and a post-dilution line 11. For example, downstream of the blood pump 19 and upstream of the blood treatment unit 4, the pre-dilution line 10 is connected to the arterial line 15. The post-dilution line 11 is connected to the venous line 16, where the post-dilution line 11 is connected to the venous drip chamber 13 in the venous line 16. The main line 9 is equipped with a supply flow rate Q IR The flow control device 12 is arranged to adjust the predilution flow rate Q of the replacement fluid in the predilution line 10. pre and the post-dilution flow rate of the substitution fluid in the post-dilution line 11. The flow control device 12 may include a first flow restriction 12A arranged to the pre-dilution line 10, and a second flow restriction 12B arranged to the post-dilution line 11. Alternatively, the flow control device 12 may include a common flow restriction (not shown) fitted to the pre-dilution line 10 and the post-dilution line 11. In use, the upstream end of the main line 9 is connected to a substitution fluid source (not shown). Therefore, the pre-dilution line 10 is arranged for infusing the substitution fluid upstream of the treatment unit 4. In addition, the post-dilution line 11 is arranged for infusing the substitution fluid downstream of the treatment unit 4.
[0048] The dialysis fluid and the replacement fluid may be the same kind of fluid and may come from the same source. The fluid may be an electrolyte and / or a buffer solution. The replacement fluid may also be referred to as an infusion fluid or a replacement fluid.
[0049] The renal replacement therapy system 1 further comprises a control circuit 30, which comprises a control unit 31. The control unit 31 comprises a processing unit 32 and a storage unit 33. The control unit 31 is configured to control the system 1 according to the control instructions. Therefore, the control unit 31 is programmed to control the system 1 according to the control instructions. The control circuit 30 comprises a sensor 24 arranged on the arterial line 15 just upstream of the blood treatment unit 4, the sensor 24 being used to supply a signal P related to the blood pressure at the inlet of the blood treatment unit 4. bi Alternatively, the blood pressure in the arterial line 15, i.e. the outlet pressure from the blood pump 19, can be calculated from the energy consumption of the blood pump 19, e.g. by measuring the power consumed by the motor 37 of the blood pump 19 (see e.g. US Pat. No. 6,585,675 B1). If the speed and physical parameters of the motor 37 are known, e.g. based on the current I consumed by the motor 37B , the torque generated by the motor 37 can be calculated. The torque consumed by the motor 37 is the arterial pressure P in (inlet pressure of the blood pump 19), system pressure P bi and the torque required to compress the pump section. System pressure P bi It can be expressed as P bi =(T motor -T tube )·K conv +P in , where T motor is the total torque output by the motor, T tube is the torque required to compress the pump section (constant of the system), K conv is the conversion constant of the system from torque to pressure. Since it is preferred to compensate for T using time and temperature tube and K conv Since the system is constant, the motor current I can be used directly B to indicate the blood pump output pressure, thereby indicating the system pressure P bi , and thus indicates the system pressure P bi The control circuit 30 further comprises a sensor 26 arranged on the venous line 16 just downstream of the blood treatment unit 4, the sensor 26 being used to supply a signal P related to the blood pressure at the outlet of the blood treatment unit 4. bo The control circuit 30 further comprises a sensor 34 arranged on the supply line 17 for supplying a signal P related to the dialysis fluid pressure at the inlet of the blood treatment unit 4. di The control circuit 30 further comprises a sensor 35 arranged on the discharge line 18 for supplying a signal P related to the dialysis fluid pressure at the outlet of the blood treatment unit 4. do The control circuit 30 further comprises a sensor 27 arranged on the supply line 17 for supplying a signal Q related to the dialysis fluid flow rate at the inlet of the blood treatment unit 4. di The control circuit 30 further comprises a sensor 25 arranged on the discharge line 18 for supplying a signal Q related to the dialysis fluid flow rate at the outlet of the blood treatment unit 4 (and downstream of any auxiliary lines 21). drainThe control circuit 30 further includes a blood concentration sensor 23 arranged somewhere along the arterial line 15, the blood concentration sensor 23 being arranged upstream of the connection of the predilution line 10 to the arterial line 15, or being arranged downstream of the connection of the predilution line 10 to the arterial line 15. The blood concentration sensor 23 is arranged to generate a blood concentration signal C related to the blood concentration of the blood in the arterial line 15 upstream of the connection of the predilution line 10 to the arterial line 15 or downstream of the connection of the predilution line 10 to the arterial line 15. E It should be understood that the described system 1 is merely an example and that the system 1 may not include all of the above-described sensors. However, the system 1 may alternatively include more and / or other sensors than those described.
[0050] Despite Figure 1 Not shown, but the renal replacement therapy system 1 may include at least one system for preparing a dialysis fluid and / or a substitution fluid, including, for example, an arrangement for mixing one fluid or multiple fluids. This may be referred to as online preparation of a dialysis fluid and / or a substitution fluid. In the following disclosure, online preparation of the fluids used is assumed. The system may also include at least one heater arranged to heat the dialysis fluid and / or the substitution fluid, and at least one degassing unit for degassing the dialysis fluid and / or the substitution fluid. The renal replacement therapy system 1 may also include various monitoring devices, including sensors and optional alarms, the monitoring devices being used to detect leaks anywhere in the system 1, to detect abnormal behavior, and to monitor various parameters, such as conductivity, temperature, density, pH, and other blood parameters, fluid parameters, and / or system parameters.
[0051] For example, one or more measured parameter values P are received by the control unit 31 for controlling the system 1. bi , P bo , P di , P do , Q di , Q drain and C E , and blood flow rate Q B , the flow rates Q of the discharge pump 29 and the fresh dialysis fluid pump 20 di and Q drain , weight loss rate WLR, ultrafiltration flow rate UFR across the membrane, infusion flow rate Q IR , any pre-dilution flow rate Q pre , any post-dilution flow rate Q post and any current I BThe control unit 31 is configured to calculate, based on the control instructions, parameters such as TMP, clearance K, UF coefficient, UFR, and others based on the received parameters. TMP can be expressed as the pressure difference between the blood pressure in the blood compartment 5 and the fluid pressure in the fluid compartment 6. Therefore, TMP can be determined by calculating the difference between the blood pressure in the blood compartment 5 and the pressure in the fluid compartment 6. The blood pressure in the blood compartment 5 can be determined by P bo or P bi or P bi and P bo The fluid pressure in the fluid chamber 6 can be determined by P do or P di or P do or P di The TMP can be calculated as P bo , P bi or (P bi and P bo ) and P do , P di or (P di and P do ) between any of the average values. For example, TMP can be calculated as the post-filtration pressure P bo With P do Alternatively, TMP is calculated as the average of the blood pressures in the blood compartment 5 (i.e., P bi and P bo The average value of P in the downstream of fluid compartment 6 do As another alternative, TMP is calculated as the average of the blood pressures in the blood compartment 5 (i.e., P bi and P bo The average value of the fluid pressure in the fluid compartment 6 (i.e., P di and P do In practice, the control unit 31 issues output signals for controlling the flow control device 12 (e.g., the restriction devices 12A and 12B), the infusion pump 28, and in some embodiments, the fresh dialysis fluid pump 20, the drain pump 29, the ultrafiltration pump 22, and the blood pump 19, according to control instructions as will become clear in the following description. For example, the control unit 31 may be configured to generate output signals for adjusting the fresh dialysis fluid flow rate Q di The control signal M and the control signal Q used to adjust the flow rate Q of the used fluid drain In addition, the control unit 31 may be configured to generate a control signal S for adjusting the flow rate WLR generated by the ultrafiltration pump 22. The control unit 31 may also be configured to generate a control signal S for adjusting the blood flow rate Q B The control signal B.
[0052] The control unit 31 may also be configured to monitor one or more of the above sensor values over time and calculate a change or changes in one or more parameters in the Δ value. bi , ΔP bo , ΔP di , ΔP do , ΔQ di , ΔQ drain , ΔC E , ΔQ B , ΔQ di , ΔQ drain , ΔWLR, ΔUFR, ΔQ IR , ΔQ pre , ΔQ post , ΔI B , ΔTMP, ΔK, ΔUF coefficients.
[0053] The first flow restriction 12A and the second flow restriction 12B can be controlled independently. Thus, the first flow restriction 12A arranged on the predilution line 10 is arranged to adjust the flow rate Q in the predilution line 10. pre The second flow restriction device 12B arranged on the post-dilution line 11 is arranged to adjust the flow rate Q in the post-dilution line 11 post The flow restriction devices 12A, 12B may be valve groups. The valve groups may be electromechanically actuated valve groups. One or both of the flow restriction devices 12A, 12B may instead be a pump or a plurality of pumps (not shown) arranged on the pre-dilution line 10 and the post-dilution line 11, respectively.
[0054] In use, the flow rate of the replacement fluid is adjusted by adjusting the delivery of the replacement fluid by the infusion pump 28. The control unit 31 is configured to generate a control signal L to adjust the flow rate Q of the fluid generated by the infusion pump 28. IR The settings of the flow restrictions 12A and 12B thereafter determine whether the flow should be directed in the pre-dilution line 10 or in the post-dilution line 11. The control unit 31 may be configured to generate a control signal G1 to adjust the first flow restriction 12A and a control signal G2 to adjust the second flow restriction 12B. According to some embodiments, the pre-dilution flow Q pre and post-dilution flow Q post That is, if the first flow restriction device 12A allows the flow Q pre , then the second flow restriction device 12B stops the flow Q post Vice versa, if the second flow restriction device 12B allows the flow rate Q post , then the first flow restriction device 12A stops the flow Q preOf course, both the first flow restriction device 12A and the second flow restriction device 12B can stop their flow rates Q pre and Q post , to achieve complete non-dilution. It is also possible to control the infusion pump 28 to stop the flow rate Q IR According to some embodiments, the control of the infusion pump 28 and the control of the flow control device 12 are synchronized. "Flow rate" is a synonym for "flow rate" here.
[0055] The system 1 can be set to a number of different modes to be able to automatically carry out different kinds of treatments, such as hemofiltration (HF), hemodiafiltration (HDF) or ultrafiltration (UF). For example, UF can be switched between a post-dilution mode, a pre-dilution mode, a simultaneous post-dilution and pre-dilution mode and also a non-dilution mode without manual intervention and also during the treatment, thanks to the flow control device 12 and the infusion pump 28.
[0056] In the case of a system 1 with online preparation, the total ultrafiltration (UF) across the membrane 7 can be controlled by the ultrafiltration pump 22 (or the bleed pump 29 if there is no separate ultrafiltration pump 22) and the infusion pump 28 in two ways; in volumetric mode and in TMP mode. In both modes, the flow rate Q di +WLR and flow rate Q drain The difference between the UF pump 22 and the discharge pump 29 is controlled so that the difference is consistent with the desired weight loss rate WLR. Figure 1 In contrast to the situation shown, the ultrafiltration pump 22 and the flow line 21 do not exist. Figure 1 In volume mode, the infusion pump 28 maintains a constant flow rate Q IR , and TMP is allowed to change. In TMP mode, by controlling the infusion flow rate Q of the infusion pump 28 IR Control is performed to keep the desired TMP constant and the infusion flow rate Q IR Eventually, the state will be such that UFR = WLR + Q IR Therefore, this relationship is maintained in both modes. The control unit 31 is configured to control the system 1 to be in volume mode or TMP mode.
[0057] Once blood treatment begins, the membrane 7 may begin to clog due to membrane fouling. During the first few minutes, proteins in the blood are adsorbed or deposited on the surface of the membrane 7 and thus on the surface of the pores of the membrane 7, which results in a change in the behavior of the membrane. This phenomenon is referred to herein as initial clogging and is generally considered to be irreversible in nature. Some recent membranes are designed with initial clogging in mind so that they reach their nominal filtration properties after the initial clogging is formed.
[0058] As the process continues, a secondary film of material resulting from concentration polarization builds up on the surface of membrane 7. This secondary film can be controlled by high shear on the membrane surface if high shear can be tolerated in operation.
[0059] In order to reduce membrane fouling, the control instructions include determining a value of a system parameter during treatment, and determining a membrane fouling indication of a membrane 7 in the blood treatment unit 4 based on a predetermined criterion of the determined system parameter value. In response to such an indication, the control instructions include activating an automatic anti-fouling measure, the automatic anti-fouling measure comprising: in order to produce a flush of the blood treatment unit 4, during at least one time period Δt1, respectively, from the pre-dilution flow rate Q pre and post-dilution flow rate Q post The current flow rate temporarily increases the predilution flow rate Q pre and temporarily reduce the dilution flow rate Q post The current value of the pre-dilution flow rate is, for example, the value of the pre-dilution flow rate just before the anti-fouling measure is activated, the average value of the pre-dilution flow rate before the anti-fouling measure is activated, or the set value of the pre-dilution flow rate. The current value of the post-dilution flow rate is, for example, the value of the post-dilution flow rate just before the anti-fouling measure is activated, the average value of the post-dilution flow rate before the anti-fouling measure is activated, or the set value of the post-dilution flow rate.
[0060] Temporarily increase the predilution flow rate Q pre Including the pre-dilution flow rate Q pre Increased to a value exceeding the post-dilution flow rate Q before the anti-fouling measures are activated post Therefore, this value is the post-dilution flow rate Q post The current value of the post-dilution flow rate Q post The current value of is the post-dilution flow rate Q before it is changed due to antifouling measures post The value of, for example, the post-dilution flow rate Q just before the antifouling measures are activated post The estimated or measured value of the post-dilution flow rate before the anti-fouling measure is activated is then used, or the average value of the post-dilution flow rate before the anti-fouling measure is activated. The shear force in the blood compartment 5 is then only temporarily increased, but is sufficient to reduce or remove the secondary membrane buildup. The volume of the pre-dilution fluid becomes limited and affects the composition of the blood only for a short period of time. Therefore, the robustness of the treatment can be maintained, and the efficiency of the treatment is increased because the secondary membrane is reduced. In the following, the pre-dilution flow rate Q is increased during a limited period of time Δt1 pre and the reduced dilution flow rate Q postis called a "temporary flush". The pre-dilution flow rate may be increased from a zero flow rate, and thus from no pre-dilution flow rate at all. Thus, the current pre-dilution flow rate mentioned above may be zero. The automatic anti-fouling measure is automatically performed by the system 1 without any manual intervention. After completion of the anti-fouling measure, the system 1 automatically returns to normal operation with its previously set parameters, or may rewrite its parameters to cope with the performed anti-fouling measure.
[0061] The time period Δt1 may have a length between approximately 0.1 seconds and 6 seconds, and more preferably, between 1 second and 3 seconds.
[0062] The control instructions may include temporarily stopping the post-dilution flow rate Q during at least one time period Δt1 post Therefore, during the time period Δt1, the pre-dilution flow rate Q pre Exceeding the post-dilution flow rate Q before starting antifouling measures post has a value of 100% and up to 400%, while during the period Δt1, the post-dilution flow rate Q post is zero, or close to zero. For example, during the time period Δt1, the pre-dilution flow rate Q pre The post-dilution flow rate Q post 110%, 130%, 150%, 200%, 250%, 300%, 350% or 400% of the value of pre The post-dilution flow rate Q post All pre-dilution flow rates Q pre Relationships should be understood to be within a certain margin.
[0063] During normal treatment, the pressure in the fluid compartment 6 is usually lower than the pressure in the blood compartment 5 in order to draw excess fluid from the patient. In order to enhance the effect of the above-mentioned temporary flushing, the negative pressure in the fluid compartment 6 of the blood treatment unit 4 can be reduced, equalized or even reversed during the same at least one time period Δt1 compared to the pressure in the fluid compartment 6 during normal treatment, so that a temporary reduction in the ultrafiltration rate across the semipermeable membrane 7 is achieved. In order to reduce the negative pressure in the fluid compartment 6 relative to the blood pressure in the blood compartment 5, it is meant here to reduce the pressure difference between the blood compartment 5 and the fluid compartment 6, eventually to a point where the pressure in the fluid compartment 6 is higher than the pressure in the blood compartment 5. These modes, i.e., reducing, equalizing or even reversing the negative pressure in the fluid compartment 6 during Δt1, can be achieved by adjusting the dialysis fluid flow rate in the supply line 17 and / or the spent fluid flow rate Q in the discharge line 18. drain and / or the WLR in the auxiliary line 21. For example, in HF processing or HDF processing, the control instruction may include temporarily stopping the WLR in the auxiliary line 21 (assuming the same flow rate Q in HDFdrain and Q di ). As a result, the pressure in the fluid compartment 6 will be zero or close to zero, and the secondary membrane accumulated on the membrane 7 in the blood compartment 5 will become easier to loosen from the membrane 7. Alternatively, in addition to stopping the WLR, the spent fluid flow rate Q can also be reduced or stopped by controlling the drain pump 29 towards or towards zero flow rate. drain . Then, since the fresh dialysis fluid pump 20 is still supplying dialysis fluid to the fluid compartment 6, the pressure in the fluid compartment 6 will gradually become less negative (compared to the pressure in the blood compartment 5). After a short while, the pressure in the blood treatment unit 4 will be equalized and, therefore, the pressure in the fluid compartment 6 will be the same as the pressure in the blood compartment 5. However, since there is still blood flowing in the blood compartment 5, there will be a pressure gradient along the membrane 7. After a while, the pressure in the fluid compartment 6 becomes greater than the pressure in the blood compartment 5, and the dialysis fluid begins to pass through the membrane 7 to the blood compartment 5 and thereby pushes any final particles captured in the secondary membrane accumulation and pores into the blood compartment 5. The pushed particles and particle aggregates can then be washed away by the increased blood flow rate in the blood compartment 5. Before the blood is returned to the patient, the filter in the venous drip chamber 13 collects any aggregates that are considered too large to remain in the blood.
[0064] When the pressure in the fluid compartment 6 becomes more positive than the pressure in the blood compartment 5, the dialysis fluid is pushed into the blood compartment 5. This corresponds to a negative UFR. The controlled infusion of the dialysis fluid from the fluid compartment 6 through the membrane 7 and into the blood compartment 5 can be referred to as backwash of the membrane 7. According to some embodiments, the anti-fouling measure includes performing a backwash, which includes infusing a certain volume of dialysis fluid from the fluid compartment 6 through the membrane 7 into the blood compartment 5. The backwash is established by temporarily reducing the ultrafiltration rate. Therefore, the controlled infusion of the dialysis fluid can be achieved by controlling the pressure in the fluid compartment 6 compared to the pressure in the blood compartment 5, so that the pressure in the fluid compartment increases positively and becomes greater than the pressure in the blood compartment 5. This pressure increase can be achieved by controlling any one of the fresh dialysis fluid pump 20, the ultrafiltration pump 22 and / or the discharge pump 29. For example, as previously explained, in order to positively increase the pressure in the fluid compartment 6, the drain pump 29 and the ultrafiltration pump 22 may be controlled to reduce or stop their flow rates Q, respectively. drain Alternatively or in addition, in order to positively increase the pressure in the fluid compartment 6, the fresh dialysis fluid pump 20 may be controlled to increase the fresh dialysis fluid flow rate Q di. Alternatively, the pressure increase may be achieved by controlling one or more valves arranged to regulate the flow rate in the discharge line 18, for example the flow rate in the flow restriction 36 and / or the flow rate in the auxiliary line 21. According to some examples, the controlled volume of dialysis fluid infused during backwashing is between 1 ml and 40 ml, more preferably between 2 ml and 10 ml. The time period Δt1 for infusing this volume is between 0.1 seconds and 6 seconds, more preferably between 1 second and 3 seconds. If the controlled volume is zero, there is no backwashing, however, the negative pressure acting on the secondary membrane from the fluid chamber 6 will decrease and may become zero, making it easier for the secondary membrane to loosen from the actual membrane 7. The backwashing may be performed as a continuous separate infusion, for example during the time period Δt1.
[0065] Just before, for example, a few seconds before the infusion of dialysis fluid during backwashing is performed, the blood pump 19 can be stopped. Thereby, the pressure gradient present in the blood compartment 5 during the normal blood flow rate through the blood compartment 5 is reduced. Then, the backwashing performed thereafter will be substantially equal in all sections of the blood treatment unit 4. Since the pressure of the blood pumped from the blood compartment 5 to the membrane 7 is then removed, the backwashing effect can be enhanced. The blood pump 19 can be stopped for a predetermined length of time, for example, the same length of time as the length of time for infusion of dialysis fluid during backwashing, for example at least one time period Δt1. Instead of stopping the blood pump 19, the speed of the blood pump 19 can be reduced. The pressure gradient in the blood compartment 5 will not be reduced as much as described above, but the pressure on the membrane 7 from the pumped blood is reduced and the effect of the backwashing can be enhanced. After the backwashing, the blood pump 19 returns to normal operation.
[0066] After the automatic anti-fouling measures and outside the time period Δt1, the flow rate Q di , Q drain , WLR (if any exists), Q B , Q IR , Q pre and Q post However, the total ultrafiltration rate UFR may be automatically increased and / or the post-dilution flow rate Q postCan be automatically reduced to compensate for the excess volume infused into the blood during the anti-fouling measures, and compensate for any reduced UFR. For each treatment, determine the desired UF volume that should be extracted from the patient during the treatment. In addition, during the anti-fouling measures, the actual extracted UF volume is continuously monitored by system 1. Therefore, the temporary reduction of UFR caused by the anti-fouling measures is known and can be compensated during the remaining treatment. In other words, the control instruction may include controlling the ultrafiltration rate after the anti-fouling measures so that during the remaining treatment, any temporary reduction in the ultrafiltration rate and / or the increase in the pre-dilution flow rate are compensated. For example, if the fluid introduced into the extracorporeal blood flow is more than the initially calculated fluid, then the excess fluid of this amount should be extracted, for example, by increasing the UFR. In addition, the control instruction may include controlling the post-dilution flow rate after the anti-fouling measures so that during the remaining treatment, for example, by increasing the post-dilution flow rate, the temporary reduction of the post-dilution flow rate is compensated. Thus, the anti-fouling measures will not have any effect on the amount of fluid extracted from the patient.
[0067] As described above, based on predetermined criteria for the determined system parameter value, the automatic anti-fouling measure is activated whenever the system parameter value indicates membrane fouling. The system parameter to be determined may be based on the current I consumed by the motor 37 of the blood pump 19. B 、System pressure P bi , ultrafiltration rate UFR, transmembrane pressure TMP, blood concentration C E , UF coefficient, infusion flow rate Q IR , pre-dilution flow rate Q pre and / or post-dilution flow rate Q post One or more of. As previously explained, these system parameter values may be sensor values received by the control unit 31, or system parameter values calculated by the control unit 30 by using known equations and the received sensor values. According to some embodiments, the predetermined criterion comprises a limit value of the system parameter value. According to some other embodiments, the predetermined criterion comprises a limit value of a change in the system parameter value. The control instructions also include comparing the determined system parameter value (or the change in the system parameter value) with the limit value of the system parameter value (or the limit value of the change in the system parameter value), respectively, and controlling the anti-fouling measures based on the comparison result. Therefore, the control instructions may include instructions for controlling the activation and / or the length of at least one time period Δt1 based on the comparison result. Reference will be made below to Figure 2-Figure 3 An example illustrating such activation.
[0068] According to some embodiments, the control instructions include synchronizing the time of backwashing with the time of temporary flushing. pre The temporary increase time and post-dilution flow rate Q postThe time of temporary reduction is controlled to perform the time of temporary flushing. Backwashing can be synchronized with temporary flushing, for example, so that the infusion or multiple infusions of dialysis fluid are performed during the same time period or multiple time periods Δt1 as the temporary flushing. Then, the infusion of one volume or multiple volumes of dialysis fluid is performed during the same time period or multiple time periods Δt1. Outside of at least one time period Δt1, the dialysis system 1 returns to normal operation without activating anti-fouling measures. For example, the control instruction includes synchronizing the time of backwashing with the time of flushing, so that during a part of the same time period Δt1 or the entire same time period Δt1, when flushing affects the blood treatment unit 4, the backwashing affects the blood treatment unit 4 at the same time. Alternatively, the control instruction includes synchronizing the time of backwashing with the time of flushing, so that the backwashing affects the blood treatment unit 4 earlier than the flushing affects the blood treatment unit 4. Then, during a part of the same time period Δt1, backwashing and flushing can affect the blood treatment unit 4 at the same time, however, backwashing can be started and established first, and flushing is performed thereafter. Therefore, when flushing is started and performed, backwashing can be in progress. Alternatively, backwashing is first performed during the first sub-period Δt1 and flushing is subsequently performed during the remaining duration of the time period Δt1 .
[0069] The mentioned stopping of the blood pump 19 may be performed during the same time period or multiple time periods Δt1, so that the blood flow is stopped during the same time period or multiple time periods Δt1. Alternatively, the blood pump 19 may be stopped during the same length of time as Δt1, but the blood pump 19 may be controlled to stop just before, for example, a few seconds of the time period Δt1 when flushing starts. pre is infused downstream of the blood pump 19, so stopping the blood pump 19 will not affect the pre-dilution flow rate Q pre . However, the fluid in the blood compartment 5 will be very clean during flushing, i.e., comprise almost only the replacement fluid infused during flushing, which can increase the effect of the combined flushing and backwashing. Instead of stopping the blood pump 19, the speed of the blood pump 19 can be reduced. The blood flow through the blood compartment 5 will then be reduced and the fluid comprises less concentrated blood compared to normal blood flow, which can increase the effect of the combined flushing and backwashing. The control unit 31 can be configured to control the speed of the blood pump 19 accordingly, for example, as described above, to be configured to reduce the speed of the blood pump 19 or to stop the blood pump 19.
[0070] According to some embodiments, the infusion of the backwash is performed only during the same time period or multiple time periods Δt1 as a temporary flush. It is also possible to perform the stopping or reducing of the used fluid flow rate Q only during the same time period Δt1. drain and / or WLR.
[0071] exist Figure 2 In the first diagram of the operating system 1, an example of a process is shown, in which the antifouling measure, here a temporary flush, is controlled in volumetric mode according to the system parameter TMP. The first diagram has the flow rate Q on its Y axis and the time t on its X axis. The diagram of the TMP of the blood treatment unit 4 overlays the first diagram and has the pressure p on its Y axis and the time t on its X axis. As can be seen from the first diagram, the process is in post-dilution mode, with the addition of a flowmeter with a continuous flow rate Q downstream of the blood treatment unit 4. post The replacement fluid is not added upstream of the blood treatment unit 4. As membrane fouling increases, TMP increases. When TMP has reached a predetermined upper limit TMP lim value, by adding the pre-dilution flow rate Q during the time period Δt1 pre The replacement fluid, while closing or reducing the post-dilution flow rate Q post , activate the antifouling measures. Here, the pre-dilution flow rate Q pre is the post-dilution flow rate Q before the time period Δt1 post Due to the flushing effect, TMP is reduced to below TMP lim After the time period Δt1, the post-dilution flow rate Q post Restore its normal speed and pre-dilution flow rate Q pre decreases to zero. TMP increases again and finally reaches TMP lim The same process is then repeated while processing is in progress.
[0072] exist Figure 3 Another example is shown in the second figure of the operating system 1, wherein, depending on the amount of substitution fluid added downstream of the blood treatment unit 4, the post-dilution flow rate Q post , controlling the antifouling measure, here a temporary flush. The second diagram has the flow rate Q on its Y axis and the time t on its X axis. Overlaid on this diagram is a diagram of the TMP of the blood treatment unit 4 and has the pressure p on its Y axis and the time t on its X axis. As can be seen from the second diagram, the treatment is in post-dilution mode, with the addition of a flow rate Q downstream of the blood treatment unit 4. post The replacement fluid is used and no fluid is added upstream of the blood treatment unit 4. During this treatment, the TMP remains constant and the treatment is therefore also in TMP mode. To achieve a constant TMP, the UFR on the filter is adjusted. As membrane fouling increases, the UFR at constant TMP decreases and in response thereto, the post-dilution flow rate Q post decreases, so less replacement fluid must be added to the extracorporeal blood flow. post Reach the predetermined flow rate Q lim By adding the pre-dilution flow rate Q during the time period Δt1pre The replacement fluid, while closing or reducing the post-dilution flow rate Q post , activate flushing. Here, the pre-dilution flow rate Q pre The post-dilution flow rate Q is adjusted to the value before the time period Δt1. post Due to the flushing effect, in order to maintain a constant TMP, UFR must be increased. After the period Δt1, the post-dilution flow rate Q post is adjusted to a higher value than before the period Δt1 to compensate for the increased UFR. post It gradually decreases again and finally reaches the predetermined lower flow rate Q lim Then repeat the same process. So the system parameters can be Q post or UFR.
[0073] During the period of antifouling measures, the treatment mode can be changed from TMP mode to volume mode. After the period of antifouling measures, the treatment mode is changed back to TMP mode again. Thus, during the antifouling measures, the desired UFR can still be achieved.
[0074] Alternatively, if Figure 3 As shown, during the period of antifouling measures, the set point of TMP can be reduced by ΔTMP. After the period of antifouling measures, the set point of TMP is changed back to the previous value. Then, during the period of antifouling measures, the pressure in the treatment unit 4 will be reduced, whereby flushing becomes more effective, because the secondary membrane accumulated on the membrane 7 will be loosened more easily from the membrane 7. During the period of antifouling measures, the set point of TMP can instead be kept constant.
[0075] In addition, anti-fouling measures can be used in response to currents above a certain current limit I B_lim The current I B The high current I B Corresponding to the corresponding high system pressure P bi Alternatively, anti-fouling measures can be taken in response to a drop below a certain ultrafiltration flow rate limit UFR. _lim The anti-fouling measures can also be activated in response to a blood concentration above a certain limit value C E_lim The blood concentration value C E And activated.
[0076] It will be appreciated that, instead of comparing absolute values, the change in the value of the system parameter may be compared with a limit of change in the value of the system parameter. When the change in the value of the system parameter is greater than the limit, the anti-fouling measure is activated.
[0077] According to another embodiment, antifouling measures may be activated in response to a specific efficiency of the treatment as determined, for example, in EP 1 729 836 B1. The efficiency parameter of the treatment may be determined by calculating the UF coefficient as follows:
[0078]
[0079] Antifouling measures can then be taken in response to the drop below a certain UF factor limit value UF coeff_lim Alternatively, the efficiency parameter can be determined by measuring the treatment clearance K (i.e., blood water clearance as described in US7435235B2, the contents of which are incorporated herein by reference). In HF, the clearance K can be determined by the patient's blood water flow rate Q BW , pre-dilution flow rate Q pre , post-dilution flow rate Q post And the expected weight loss rate WLR is calculated as follows:
[0080]
[0081] Blood flow rate Q BW is an estimate of the velocity of water in the blood, and uses the factor f BW ~0.85-0.9 multiplied by blood flow rate Q B to evaluate.
[0082] Alternatively, as an approximation, replace the blood-water flow rate Q BW , the blood flow rate Q can be used B To calculate the clearance K, we then replace Q in equation (2) with BW Change to Q B The purge K may be compared to a purge parameter limit value, and if the purge K is below the limit value, antifouling measures may be activated during the time period Δt1.
[0083] The efficiency parameter may alternatively be the conductivity in the discharge line 18 , or the concentration of at least one substance contained in the fluid in the discharge line 18 . Figure 1 The system 1 is then arranged with a sensor 14 for sensing such a fluid parameter, i.e. conductivity or concentration. The conductivity can be compared with a conductivity limit value, and if the conductivity is greater than the limit value, anti-fouling measures can be activated. Furthermore, the concentration of at least one substance can be compared with a concentration limit value of the at least one substance, and if the concentration is greater than the limit value, anti-fouling measures can be activated.
[0084] The present disclosure also relates to a method for use in a renal replacement therapy system. The method can be used Figure 11 is performed by the system 1 shown in . The system 1 can be arranged for any one or all of UF (ultrafiltration), HF (hemofiltration) or HDF (hemodiafiltration) treatments. The system 1 can also be arranged for all treatments, and the control unit 31 in the system 1 will control the system 1 according to the input to the system 1 to perform a specific type of treatment related to the input. The computer program P is loaded into the storage unit 33 of the control unit 31, and the computer program P includes computer instructions (i.e., control instructions) so that when the computer program P runs on the processing unit 32, the control unit 31 performs the method according to any method steps disclosed herein. The processing unit 32 may include one or more central processing units (CPUs). The computer program P may reside on a computer program product, such as a storage unit in a computer or on a server, on a CD-ROM, a memory stick, or the like.
[0085] Now refer to Figure 4 and refer to the flowchart in Figure 1 The method is described in detail with reference to the system description in . Before activating the method, a treatment in a post-dilution mode, such as post-dilution HF or post-dilution HDF, has been started, A1. During the treatment, the method comprises determining a system parameter value, A2. The method further comprises determining a membrane fouling indication of the membrane 7 based on a predetermined criterion for the determined system parameter value, A3. In response to determining such an indication, when the predetermined criterion is met, the method proceeds with activating an automatic anti-fouling measure as previously described, A4. If the criterion is not met, the treatment is terminated A5 and the method returns to step A2. The anti-fouling measure comprises A4: during at least one time period Δt1, respectively from the pre-dilution flow rate Q pre and post-dilution flow rate Q post The current flow rate temporarily increases the predilution flow rate Q pre and temporarily reduce the dilution flow rate Q post , in order to produce a flushing of the blood treatment unit 4, wherein the temporary increase includes the predilution flow rate Q pre Increased to a value exceeding the post-dilution flow rate Q before the anti-fouling measures are activated post has a value of 100%. Pre-dilution flow rate Q pre The current flow rate can be zero, so the pre-dilution flow rate Q pre The anti-fouling measures may include temporarily stopping the post-dilution flow rate Q during at least one time period Δt1. post .
[0086] As already explained, based on I B , P bi , TMP, C E , Q post, UFR, UF factor, or other efficiency parameters of the process may indicate membrane fouling of the membrane 7, and the system parameter values may be determined based on the system parameter values I B , P bi , TMP, C E , Q post , UFR, UF factor or other efficiency parameters of the process to control the temporary flushing. The predetermined criteria may include the limit value of the system parameter value, or the limit of the change of the system parameter value. The method may include respectively setting the determined system parameter value I B , P bi , TMP, C E , Q post , UFR or UF coefficient with the system parameter limit value, and control the antifouling measures based on the comparison result. The method may also include comparing the determined removal value K or the conductivity of the waste liquid with the limit value of the removal parameter or conductivity, and controlling the antifouling measures based on the comparison result. In particular, by monitoring the system parameter or efficiency parameter, the time of temporary flushing (i.e., the activation of the time period Δt1) can be controlled, and the temporary flushing is activated when the system parameter value or efficiency parameter exceeds a specific limit value or range. At least one time period Δt1 can have a length of 0.1 seconds to 6 seconds, preferably, a length of 1 second to 3 seconds. The method may include determining the length of the time period Δt1 based on the comparison result. For example, if the system parameter value exceeds its limit value by a large amount, the time period Δt1 can be longer than the time period if the system parameter value exceeds its limit value by a small amount. The method may also include determining the values of different system parameters, and determining the membrane fouling indication based on predetermined criteria for a plurality of different system parameter values, respectively. Then, in order to activate the automatic antifouling measures, at least one, a subset or all of the system parameter values must indicate membrane fouling of the membrane.
[0087] The “temporary increase” includes the increase relative to the post-dilution flow rate Q post Reduce the post-dilution flow rate Q before post Temporarily increase the predilution flow rate Q by pre For example, the method may include temporarily increasing the predilution flow rate Q pre During at least one time period Δt1, the pre-dilution flow rate Q pre Temporarily increase to exceed the post-dilution flow rate Q post 100% to increase to the post-dilution flow rate Q post 400%. Reduce the post-dilution flow rate Q post It may include temporarily stopping the post-dilution flow rate Q during at least one time period Δt1. post During processing, the method continues until the processing ends A5. If the processing has stopped, the method also stops A6.
[0088] Antifouling measures may include performing a membrane 7 ( Figure 1 ) as previously described. Backwashing may include infusing a volume of dialysis fluid into the blood treatment unit 4 in order to enhance the flushing effect on the membrane 7. This means that one or more volumes of dialysis fluid may enter the blood compartment 5 from the fluid compartment 6 through the semipermeable membrane 7. Flushing included in the backwash may also be performed between time periods Δt1. The method may include synchronizing the time of the backwash with the time of the flush so that the backwash affects the blood treatment unit 4 at the same time and / or earlier than the flush affects the blood treatment unit 4. That is, the time is synchronized so that one or more infusions of one or more volumes of dialysis fluid are performed during at least one time period Δt1.
[0089] Thus, during the same at least one time period Δt1, the negative pressure in the fluid compartment 6 of the blood treatment unit 4 may be reduced, equalized or even reversed compared to the pressure in the fluid compartment 6 during normal treatment. According to some embodiments, the change in pressure is performed only during the at least one time period Δt1.
[0090] While the invention has been described in connection with what are presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not limited to the disclosed embodiments, but on the contrary, the invention is intended to cover various modifications and equivalent arrangements included within the purview of the appended claims.
Claims
1. A system (1) for renal replacement therapy, comprising a blood treatment unit (4), the blood treatment unit (4) being arranged to be connected to a blood circuit (2) for extracorporeal blood circulation, the blood circuit (2) comprising an arterial line (15) and a venous line (16), wherein: The blood treatment unit (4) comprises a blood compartment (5) and a fluid compartment (6) separated by a semipermeable membrane (7), and the system (1) further comprises: - a blood pump (19) arranged to generate a blood flow rate Q in the arterial line (15) B ; - a predilution circuit (10) arranged for infusing a substitution fluid upstream of said treatment unit (4); - a post-dilution circuit (11) arranged for infusing a substitution fluid downstream of said treatment unit (4); - a flow control device (12) arranged to adjust the predilution flow rate Q of the substitution fluid in the predilution circuit (10) pre and the post-dilution flow rate Q of the replacement fluid in the post-dilution line (11) post ; - a control unit (31) configured to control the system (1) according to control instructions, characterized in that The control instructions include: determining a system parameter value during treatment and determining a membrane fouling indication of the semipermeable membrane (7) based on a predetermined criterion of the determined system parameter value, and activating an automatic anti-fouling measure, the automatic anti-fouling measure including: in order to produce a flush of the blood treatment unit (4), during at least one time period Δt1, respectively, from a pre-dilution flow rate Q pre and post-dilution flow rate Q post The current flow rate temporarily increases the predilution flow rate Q pre and temporarily reduce the dilution flow rate Q post , wherein the temporary increase in pre-dilution flow rate Q pre Including the pre-dilution flow rate Q pre Increased to a value exceeding the post-dilution flow rate Q before the automatic anti-fouling measures are activated post has a value of 100%, Wherein, the predetermined standard includes a limit value of the system parameter value, The at least one time period Δt1 has a length of 0.1 seconds to 6 seconds.
2. The system (1) according to claim 1, wherein: The automatic anti-fouling measure comprises temporarily stopping the post-dilution flow rate Q during the at least one time period Δt1 post .
3. The system (1) according to claim 1 or 2, further comprising: A dialysis fluid circuit (3) comprising a supply line (17) arranged for supplying dialysis fluid to the blood treatment unit (4) and a discharge line (18) arranged for withdrawing used fluid from the blood treatment unit (4), wherein the automatic anti-fouling measure comprises performing a backwash, the backwash comprising infusing a volume of dialysis fluid from the fluid compartment (6) through the semipermeable membrane (7) into the blood compartment (5).
4. The system (1) according to claim 3, wherein: The control instruction includes: controlling the time of the backwashing and the time of the flushing so that the backwashing starts earlier than the flushing.
5. The system (1) according to any one of claims 1, 2 and 4, wherein: The control instruction includes comparing the determined system parameter value with a limit value of the system parameter, and controlling the automatic anti-fouling measure based on the comparison result.
6. The system (1) according to claim 3, wherein: The control instruction includes comparing the determined system parameter value with a limit value of the system parameter, and controlling the automatic anti-fouling measure based on the comparison result.
7. The system (1) according to claim 5, wherein: The control instruction includes determining a length of the at least one time period Δt1 based on the comparison result.
8. The system (1) according to claim 6, wherein: The control instruction includes determining a length of the at least one time period Δt1 based on the comparison result.
9. The system (1) according to any one of claims 1, 2, 4, 6, 7, 8, wherein: The system parameter to be determined is based on the current I consumed by the motor (37) of the blood pump (19). B 、System pressure P bi , the transmembrane pressure TMP across the blood treatment unit (4), the post-dilution flow rate Q post , ultrafiltration UF coefficient, blood concentration C E , the clearance K of the process and / or one or more of other efficiency parameters of the process.
10. The system (1) according to claim 3, wherein: The system parameter to be determined is based on the current I consumed by the motor (37) of the blood pump (19). B 、System pressure P bi , the transmembrane pressure TMP across the blood treatment unit (4), the post-dilution flow rate Q post , ultrafiltration UF coefficient, blood concentration C E , the clearance K of the process and / or one or more of other efficiency parameters of the process.
11. The system (1) according to claim 5, wherein: The system parameter to be determined is based on the current I consumed by the motor (37) of the blood pump (19). B 、System pressure P bi , the transmembrane pressure TMP across the blood treatment unit (4), the post-dilution flow rate Q post , ultrafiltration UF coefficient, blood concentration C E , the clearance K of the process and / or one or more of other efficiency parameters of the process.
12. The system (1) according to any one of claims 1, 2, 4, 6, 7, 8, 10, 11, wherein: The control instructions include controlling the ultrafiltration rate and / or the post-dilution flow rate after the automatic anti-fouling measure so that any temporary changes in the ultrafiltration rate and / or the post-dilution flow rate are compensated during the remaining treatment.
13. The system (1) according to claim 3, wherein: The control instructions include controlling the ultrafiltration rate and / or the post-dilution flow rate after the automatic anti-fouling measure so that any temporary changes in the ultrafiltration rate and / or the post-dilution flow rate are compensated during the remaining treatment.
14. The system (1) according to claim 5, wherein: The control instructions include controlling the ultrafiltration rate and / or the post-dilution flow rate after the automatic anti-fouling measure so that any temporary changes in the ultrafiltration rate and / or the post-dilution flow rate are compensated during the remaining treatment.
15. The system (1) according to claim 9, wherein: The control instructions include controlling the ultrafiltration rate and / or the post-dilution flow rate after the automatic anti-fouling measure so that any temporary changes in the ultrafiltration rate and / or the post-dilution flow rate are compensated during the remaining treatment.
16. A method for managing membrane fouling of a blood treatment unit in a renal replacement therapy system (1), the renal replacement therapy system (1) comprising a blood treatment unit (4), the blood treatment unit (4) being arranged to be connected to a blood circuit (2) for extracorporeal blood circulation, the blood circuit (2) comprising an arterial line (15) and a venous line (16), wherein: The blood treatment unit (4) comprises a blood compartment (5) and a fluid compartment (6) separated by a semipermeable membrane (7), and the renal replacement therapy system (1) further comprises a blood pump (19) arranged to supply a blood flow rate Q in the arterial line (15) B a pre-dilution line (10) arranged to infuse a replacement fluid upstream of the processing unit (4); a post-dilution line (11) arranged to infuse a replacement fluid downstream of the processing unit (4); a flow control device (12) arranged to adjust a pre-dilution flow rate of the replacement fluid in the pre-dilution line (10) and a post-dilution flow rate of the replacement fluid in the post-dilution line (11); and a control unit (31), The method comprises during the process: - Determine system parameter values; - determining a membrane fouling indication of the semipermeable membrane (7) based on a predetermined criterion of the determined system parameter value; - activating automatic anti-fouling measures, which include: in order to produce a flush of the blood treatment unit (4), during at least one time period Δt1, respectively, from the pre-dilution flow rate Q pre and post-dilution flow rate Q post The current flow rate temporarily increases the predilution flow rate Q pre and temporarily reduce the dilution flow rate Q post , wherein the temporary increase in pre-dilution flow rate Q pre Including the pre-dilution flow rate Q pre Increased to a value exceeding the post-dilution flow rate Q before the automatic anti-fouling measures are activated post has a value of 100%, Wherein, the predetermined standard includes a limit value of the system parameter value, The at least one time period Δt1 has a length of 0.1 seconds to 6 seconds.
17. The method according to claim 16, wherein: The automatic anti-fouling measure comprises temporarily stopping the post-dilution flow rate Q during the at least one time period Δt1 post .
18. The method according to claim 16 or 17, wherein: The automatic anti-fouling measure comprises performing a backwash, which comprises infusing a volume of dialysis fluid from the fluid compartment (6) through the semipermeable membrane (7) into the blood compartment (5).
19. The method according to claim 18, comprising: The backwashing time is synchronized with the flushing time, so that when the flushing affects the blood treatment unit (4), the backwashing affects the blood treatment unit (4) at the same time, and / or the backwash affects the blood treatment unit (4) earlier than the flushing affects the blood treatment unit (4).
20. The method according to any one of claims 16, 17 and 19, wherein: The determined system parameter is based on the current I consumed by the motor (37) of the blood pump (19). B 、System pressure P bi , the transmembrane pressure TMP across the blood treatment unit (4), the post-dilution flow rate Q post , ultrafiltration UF coefficient, blood concentration C E , the clearance K of the process and / or one or more of other efficiency parameters of the process.
21. The method according to claim 18, wherein: The determined system parameter is based on the current I consumed by the motor (37) of the blood pump (19). B 、System pressure P bi , the transmembrane pressure TMP across the blood treatment unit (4), the post-dilution flow rate Q post , ultrafiltration UF coefficient, blood concentration C E , the clearance K of the process and / or one or more of other efficiency parameters of the process.
22. A computer program product, wherein: The computer program product comprises computer instructions which, when executed by a control unit (31), cause the control unit (31) to perform a method according to any one of claims 16 to 21.
Citation Information
Patent Citations
Blood treatment equipment and software program for controlling infusion.
EP1729836B1
Method and apparatus for blood withdrawal and infusion using a pressure controller
US6585675B1
Blood treatment equipment, method, and software program for controlling infusion in blood treatment equipment
US7435235B2
Haemodiafiltration method
WO2014095073A1
Electrolyte and pH monitoring for fluid removal processes
CN103717132A
